Kalamazoo, MI, United States of America

Kaori Mohr

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 2 CIPO patents. Top assignee: Zoetis Services LLC. Active years: 2018-2024.

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kaori Mohr: Innovator in Immunological Advancements

Introduction

Kaori Mohr, based in Kalamazoo, MI, is an accomplished inventor with a robust portfolio that includes four patents. Her work primarily focuses on the development of oil-based adjuvants that contribute significantly to the field of immunology and veterinary medicine.

Latest Patents

Among Mohr's latest innovations are formulations that comprise combinations of immunostimulating oligonucleotides, polycationic carriers, sterols, saponins, quaternary amines, TLR-3 agonists, glycolipids, and MPL-A or its analogs within oil emulsions. These inventions are crucial for preparing immunogenic compositions and vaccines, alongside their use in treating animals.

Career Highlights

Kaori Mohr is currently employed at Zoetis Services LLC, a leading company in animal health. Her innovative contributions to the field of veterinary immunology have not only advanced scientific understanding but also improved the efficacy of vaccines that protect animal health.

Collaborations

Throughout her career, Mohr has collaborated with notable colleagues, including Paul Joseph Dominowski and Dennis L Foss. These partnerships have facilitated the exchange of ideas and further propelled advancements in their joint research projects.

Conclusion

With a commitment to developing groundbreaking solutions in veterinary medicine, Kaori Mohr exemplifies the role of an innovative inventor. Her work continues to impact the health and well-being of animals, paving the way for future advancements in immunological treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…